STA-9090 (ganetespib)

ganetespib · Synta Pharmaceuticals Corp.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for STA-9090 (ganetespib), covering 2014-09-18 to 2017-04-12. Get the full timeline:

Most recent: Clinical Trial Update: STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma [Phase 2]